The Media Database That Really Understands Journalists

Explore Our Database And See What Journalists Create So You Can Better Connect 🫶

Find Out More
Login
30-Day Free Trial

Media Database N nature.com Paul Adepoju

Paul Adepoju
pauladepoju

2130 followers

Ibadan, London

Science, Media, PhD | @ONA Award Winner | Byline: @Nature, @TheLancet, @NewScientist, @SciAm, @HealthPolicyW, @Devex, @BusinessInsider

Publications:
nature.com,
bmj.com,
scientificamerican.com
Topics
africa, biomedicine, cancer research, ebola, general, infectious diseases, life sciences, malaria, metabolic diseases, molecular medicine, neurosciences, science, worldmalariaday
Recent articles
EB Special - Health Policy Watch
Apr 23, 2024
healthpolicy-watch.news
New TB vaccine on trial
Mar 24, 2024
nature.com
Un nouveau vaccin contre la tuberculose à l'essai
Mar 24, 2024
nature.com
Deputy Africa CDC Director Ahmed Ogwell Ouma To Leave Organization - Health Policy Watch
Mar 06, 2024
healthpolicy-watch.news
Malaria & Neglected Diseases - Health Policy Watch
Jan 31, 2024
healthpolicy-watch.news
WHO Board Takes On Neglected Tropical Diseases And AMR - Health Policy Watch
Jan 29, 2024
healthpolicy-watch.news
Somalia Leads Call For Urgent Action On Global Disparities In Maternal, Newborn And Child Mortality - Health Policy Watch
Jan 27, 2024
healthpolicy-watch.news
United States Unveils Four-Pronged Strategy To Eradicate Polio Globally At WHO EB - Health Policy Watch
Jan 26, 2024
healthpolicy-watch.news
Call For Swift Actions To Counter The Emerging Threat Of E-cigarettes At WHO Board - Health Policy Watch
Jan 25, 2024
healthpolicy-watch.news
Cameroon Becomes The First Of 20 African Countries To Roll Out Routine Malaria Vaccination In 2024 - Health Policy Watch
Jan 22, 2024
healthpolicy-watch.news

Find out everything there is to know

Publication resume, most loved topics, and more. Find out everything there is to know about a journalist, in our 500k+ database.

Start a 30-day free trial of BuzzSumo.

START YOUR FREE TRIAL

Already registered? Log in to your account